A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus
Status:
Completed
Trial end date:
2001-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this double-masked, pilot trial is to determine whether 20 percent thalidomide
ointment is safe and effective for the treatment of chronic discoid lupus erythematosus
(CDLE) when used under an occlusive dressing. Seventeen patients with two similar lesions
will have lesions randomized to receive either intervention or placebo therapy.